Hannah Brendan bought QNCX
December 5, 2025 · Form 4 insider transaction
Hannah Brendan bought 25,280 shares of Quince Therapeutics, Inc. at $0.94 per share, a transaction worth $23.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,280
Price
$0.94
Total value
$23.8K
InsiderHannah Brendan
RoleOfficer
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateDecember 5, 2025
Filing dateDecember 8, 2025
Shares owned after361,827
OwnershipDirect
10b5-1 planNo
AmendedNo